Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
A premium British handcrafted candy-maker seeking funds to expand and grow their business internationally. In addition to their own candy and confectionary, they also offer customers to create their own designs using natural colourings and the finest ingredients. Spun Candy have the rights to the Candy Crush app.
days to go:
Expired
investment:
£341,990
OnCare is a digital care management software that is digitising elderly care, creating a global care marketplace via the OpenTable model to care. OnCare provides care agencies with the power to plan, manage and enhance care delivery and staff communication. Their mission is to make care easier for everyone. OnCare is currently live with over 110 home-care agencies around the UK, and more than 1100 care workers. The company is planning to enter markets of Hong Kong, Canada and Israel. With the proceeds, the company will use this fund for people, office space, technology, software, hosting and marketing.
days to go:
Expired
investment:
£96,040
SRSLY Low Carb, an award-winning health food brand, specializes in high protein, low carb products to make healthy eating both convenient and delicious. They've already played a significant role in 4.5 million meals and generated over £6 million in revenue, boasting an impressive 79% repeat order rate and a 35% subscription rate. With a recent NHS England contract and the first US retail order secured, SRSLY is poised to expand into local and international retail markets with the ambition of becoming a global leader in the field. They've demonstrated market fit with customers reporting benefits like longer satiation for weight loss and better blood sugar control for those with diabetes. As 70% of adults seek healthier food options, SRSLY sees abundant opportunities to meet customer needs and empower families to make convenient, healthy, and tasty food choices.
days to go:
Expired
investment:
£274,197
Biscuiteers sell collections of hand iced biscuits for every occasion. Their aim is to offer a more unique, stylish and personalised gifting solution. Biscuiteers currently have two retail stores, one is located in Notting Hill and the other in Northcote Road.
days to go:
Expired
investment:
£1,245,660
Brew by Numbers (BBNo) is one of London's top independent brewery that has a reputation for creating diverse range of high-quality modern beers. It has brewed 380+ different beers across 37 styles, building seasonal specials, year-round favourites and barrel-aged beers and sours. BBNo is currently running 3 taprooms in both Bermondsey and Peckham. The brewery is highly ranked in the craft beer community, winning Ratebeer Top 50 beers in the World (2018), and 2 x gold in the World Beer Awards (2019). BBNo is funding to move the brewery to a larger production site in South East London and convert the current brewery site to a tank bar.
days to go:
Expired
investment:
£522,030
Personalised Protein Co (PPCo) is a direct-to-consumer supplement brand that bridges the gap between technology and fitness. Leveraging on the growing UK vitamin and supplement industry, which is worth over £800m, PPCo offers expert guidance, bespoke product, clear pricing, and consumer-friendly subscription service. More than 9,000 people have signed up for the company's pre-registered launch campaign providing it 1,200 customers and 5000+ Instagram followers. With the proceeds, the company will improve its technology, automation, and aim at acquiring new customers. PPCo is raising money to invest in its product and scale its marketing efforts.
days to go:
Expired
investment:
£192,770
